Elizabeth Holmes Film Achieves Historic Opening, Becomes Second‑Highest Grossing Nonfiction Release

TechCrunch reports that the latest documentary about Elizabeth Holmes, titled “You Can See Everything,” attracted a huge crowd, delivering the second‑biggest opening weekend ever for a documentary. This impressive launch highlights the continued public intrigue surrounding the former Theranos chief executive and her spectacular downfall.

Once celebrated as a groundbreaking biotech innovator, Holmes watched her empire crumble under fraud accusations that resulted in criminal convictions and a widely publicized trial. While her saga has already been explored in books, podcasts and news reports, the documentary offers a new, thorough examination of the personal and corporate forces behind the controversy.

Analysts point out that documentaries seldom reach blockbuster figures, which makes the movie’s results stand out. Only a single documentary has ever opened with larger receipts, placing “You Can See Everything” at the summit of a specialized market that has expanded recently due to streaming services and a surge in true‑crime interest. The robust attendance indicates a public appetite for in‑depth looks at recent tech‑sector scandals.

Observers in the industry suggest the documentary might spark renewed debate over regulatory scrutiny of health‑tech startups and could shape public opinion while Holmes deals with post‑conviction legal issues. Critics are also tracking whether the film will attract awards attention, a route frequently pursued by prominent nonfiction works that blend investigative rigor with cinematic flair.

After its strong theatrical run, the documentary is slated to transition to digital services, reaching audiences beyond the initial ticket purchasers. Its achievement mirrors a wider movement in documentary cinema that fuses courtroom drama with corporate intrigue, delivering a thorough perspective on a case that still influences discussions about innovation, accountability and media storytelling.